Delivery Order SPE2DR25D3202-SPE2DR26F8D7U
- Not listed
- The Defense Logistics Agency awarded a $2,046.60 delivery order to AmerisourceBergen Drug Corp for Junel FE 1 mg-20 mcg tablets (28-count packaging) on July 22, 2025, with completion scheduled for July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency awarded a delivery order valued at $1,904.40 to AmerisourceBergen Drug Corp for Junel FE 1 mg–20 mcg tablets (28-count packages) on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed-price, competitively awarded delivery order represents a non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $2,623.20 to AmerisourceBergen Drug Corp for the supply of Junel FE 1 mg-20 mcg tablets (28-count packages). This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and has an ultimate completion date of August 25, 2025. The delivery order was issued on August 22, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $3,747.10 to AmerisourceBergen Drug Corp for Junel FE 1 mg-20 mcg tablets (28-count packages) on August 7, 2025, with a completion date of August 8, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,398.71 to AmerisourceBergen Drug Corp for Junel FE 1.5 mg-30 mcg tablets (28-count package). This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of September 24, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as one of the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 19, 2025, for the supply of Junel FE 1 mg-20 mcg tablets in a 28-tablet package configuration. This firm fixed-price delivery order, valued at $1,141.06, represents a non-set-aside competitive award with an ultimate completion date of May 20, 2025. The performance location is identified as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order valued at $1,402.75 to AmerisourceBergen Drug Corp for Junel Fe 1 mg-20 mcg tablets (28-count packaging) on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single transaction within AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $3,637.67 delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Junel FE 1 mg-20 mcg tablets (28-count packaging). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 18, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a small-value pharmaceutical procurement falling under the company's larger federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,011.54 to AmerisourceBergen Drug Corp for the supply of Junel FE 1.5 mg-30 mcg tablets in a 28-count package. This competitively awarded, firm fixed-price contract was issued on July 31, 2025, with an ultimate completion date of August 1, 2025. The contractor will perform work at its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,810.99 to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Junel FE 1 mg-20 mcg tablets in a 28-count package. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract calls for performance completion by September 19, 2025, with the product to be delivered to or performed at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DR25D3202Indefinite Delivery Contract
- SPE2DR25D3202-SPE2DR26F8D7UDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,076.91 to AmerisourceBergen Drug Corp for Junel FE 1 mg-20 mcg tablets (28-count packaging) on November 20, 2025, with completion targeted for November 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single pharmaceutical delivery under the Defense Logistics Agency's medical supply chain operations. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to support military healthcare systems and other federal agencies. The company's extensive federal contract portfolio demonstrates its capacity to fulfill pharmaceutical procurement requirements across multiple therapeutic domains, including specialty medications, vaccines, and generic drugs for Defense Health Agency customers and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 11/20/25 |